Thursday, November 12, 2026

°

Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials

Posted Thursday, November 12, 2026 4:07 pm

Frank Vinluan (via MedCity News)

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal. The post Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

BioPharma, Pharma, biopharma nl, Blackstone Life Sciences, Clinical Trials, Deals, GLP-1 drugs, metabolic disorders, Obesity, Pfizer

Top stories

America's #1 Cancer Is More Common Than We Thought

(NewsUSA) - New estimates suggest that 4.7 million Americans are diagnosed with nonmelanoma skin cancer (NMSC) annually, while advances in treatment offer patients more choices than ever before.NMSC …

Why Women Should Find Out Their Breast Cancer Risk Earlier than You Think

(NewsUSA) - For many people, breast cancer screening becomes a priority around age 40. However, according to recommendations from the American College of Radiology® (ACR®), one of the most …

Ask About Clinical Trials on Day One

(Mitch Jelniker) - For people diagnosed with small cell lung cancer, the clinical trial conversation belongs in the very first appointment.A diagnosis of SCLC can trigger a whirlwind of appointments, …

From Uncertainty to Reassurance: How a Small Heart Monitor and Ablation Procedure Helped One Father Conquer the Unknowns of Atrial Fibrillation

(NewsUSA) - In 2018, then-52-year-old Todd Repass Jr. stood up after a meal and immediately knew something was wrong. It was terrifying. He felt weak, short of breath, and, at times, dizzy. The …

Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.

(Dr. Matthew Holman) - There is a piece of good public health news that deserves more attention: youth tobacco use in the United States has fallen to historically low levels. That progress did not …

From the web

Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion …

NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Leverages Vertically Integrated Business Model to Drive Growth and Profitability

Earth Science Tech (OTCQB: ETST) is leveraging its diversified conglomerate business model to build a vertically integrated healthcare platform while expanding its presence across real estate, asset …

InvestorNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Positions for Emerging Peptide Market with Focus on Quality, Traceability

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is positioning itself to address growing demand for quality assurance and transparency …

Is AI Really Saving Hospitals Money? A New Study Raises Questions About the Cost of AI-Driven Care

Healthcare systems are investing in AI to streamline workflows and save money, but a new study in the New England Journal of Medicine shows that AI-generated care plans might actually cost far more …

MiningNewsBreaks – Why Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z) Is ‘One to Watch’

Disseminated on behalf of Metalsource Mining Inc. and may include paid advertising. Metalsource Mining (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z) is advancing its historic Silver Hill precious and base …